Histogen to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference

Rhea-AI Summary

Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company, announced its participation in the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. The presentation will be available for on-demand listening starting January 11, 2021, at 6:00 a.m. Eastern Time on the Investors section of the Histogen website. Histogen focuses on developing innovative restorative therapeutics using hypoxia-induced multipotent cells, targeting applications for hair growth, dermal rejuvenation, joint cartilage regeneration, and spinal disk repair.

SAN DIEGO, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that it will present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference.

Presentation Details
The presentation will be available for on-demand listening beginning Monday, January 11, 2021, at 6:00 a.m. Eastern Time on the Investors section of the Histogen website at www.histogen.com, under the New and Events tab.

Webcast Link: https://journey.ct.events/view/dccb42bf-3f14-42b9-a4b2-09c945ccd06c

About Histogen
Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visit www.histogen.com.

Contact:
Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com

FAQ

When will Histogen present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference?

Histogen will present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference on January 11, 2021.

Where can I listen to Histogen's presentation from the conference?

The presentation will be available for on-demand listening on Histogen's website under the Investors section.

What is the focus of Histogen Inc.'s research?

Histogen Inc. focuses on developing restorative therapeutics for hair growth, dermal rejuvenation, joint cartilage regeneration, and spinal disk repair.

What technology does Histogen use in its therapeutics?

Histogen utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells.

What is the stock symbol for Histogen Inc.?

The stock symbol for Histogen Inc. is HSTO.